Cipher Pharmaceuticals (TSE:CPH) Stock Crosses Above Fifty Day Moving Average – Time to Sell?

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR)’s stock price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$17.24 and traded as high as C$18.10. Cipher Pharmaceuticals shares last traded at C$17.87, with a volume of 20,443 shares.

Cipher Pharmaceuticals Stock Down 0.2%

The company’s 50 day moving average price is C$17.24 and its 200 day moving average price is C$15.54. The company has a quick ratio of 2.67, a current ratio of 1.12 and a debt-to-equity ratio of 4.36. The firm has a market capitalization of C$451.77 million, a price-to-earnings ratio of 17.02 and a beta of 0.89.

Cipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) last posted its quarterly earnings data on Thursday, May 7th. The company reported C$0.33 EPS for the quarter. Cipher Pharmaceuticals had a net margin of 54.37% and a return on equity of 24.23%. The business had revenue of C$17.39 million during the quarter. As a group, research analysts forecast that Cipher Pharmaceuticals Inc. will post 1.2907348 earnings per share for the current fiscal year.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.